EID1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.165400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.068600E-01
Normal-vs-Stage2
2.273000E-01
Normal-vs-Stage3
2.497800E-01
Normal-vs-Stage4
8.342000E-01
Stage1-vs-Stage2
3.052100E-02
Stage1-vs-Stage3
2.189800E-01
Stage1-vs-Stage4
6.638600E-01
Stage2-vs-Stage3
7.739200E-01
Stage2-vs-Stage4
2.655200E-01
Stage3-vs-Stage4
3.266800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.202400E-01
Normal-vs-AfricanAmerican
6.727000E-01
Normal-vs-Asian
2.795800E-01
Caucasian-vs-AfricanAmerican
5.783000E-01
Caucasian-vs-Asian
4.042600E-01
AfricanAmerican-vs-Asian
3.419600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.799600E-01
Normal-vs-Female
6.169600E-01
Male-vs-Female
5.077800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.835600E-01
Normal-vs-Age(41-60Yrs)
5.902200E-01
Normal-vs-Age(61-80Yrs)
3.860600E-01
Normal-vs-Age(81-100Yrs)
7.609500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.785200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.761000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.357960E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.256400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.732300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.052200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.248000E-02
Normal-vs-Daily Drinker
9.182400E-02
Normal-vs-Weekly Drinker
2.667400E-01
Normal-vs-Occasional Drinker
8.551000E-01
Normal-vs-Social Drinker
5.078600E-01
Non Drinker-vs-Daily Drinker
9.036800E-01
Non Drinker-vs-Weekly Drinker
5.403600E-01
Non Drinker-vs-Occasional Drinker
1.629020E-01
Non Drinker-vs-Social Drinker
1.551430E-01
Daily Drinker-vs-Weekly Drinker
5.150200E-01
Daily Drinker-vs-Occasional Drinker
1.548030E-01
Daily Drinker-vs-Social Drinker
1.681760E-01
Weekly Drinker-vs-Occasional Drinker
3.432200E-01
Weekly Drinker-vs-Social Drinker
5.312800E-01
Occasional Drinker-vs-Social Drinker
6.548600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.002200E-01
Normal-vs-Grade 2
4.820200E-02
Normal-vs-Grade 3
1.055180E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.747000E-01
Grade 1-vs-Grade 3
1.252960E-01
Grade 1-vs-Grade 4
2.002200E-01
Grade 2-vs-Grade 3
1.545400E-01
Grade 2-vs-Grade 4
4.820200E-02
Grade 3-vs-Grade 4
1.055180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.936440E-01
Normal-vs-NonDiabetic
4.329400E-01
Diabetic-vs-NonDiabetic
2.754800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.923700E-02
Normal-vs-NoPancreatitis
4.273000E-01
Pancreatitis-vs-NoPancreatitis
1.617040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.689000E-01
Normal-vs-N1
2.495000E-01
N0-vs-N1
2.891600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.159180E-01
Normal-vs-TP53-NonMutant
7.224600E-01
TP53-Mutant-vs-TP53-NonMutant
8.960200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
